HMG-CoA Reductase Inhibitor [EPC]

359510 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 20035
1 NAUSEA 18546
2 DRUG INEFFECTIVE 18227
3 DYSPNOEA 17676
4 DIARRHOEA 16852
5 DIZZINESS 15401
6 PAIN 13711
7 ASTHENIA 13123
8 HEADACHE 12672
9 FALL 12642
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 262 0.6805
1 PALMOPLANTAR KERATODERMA 254 0.4903
2 IMMUNE-MEDIATED NECROTISING MYOPATHY 251 0.4580
3 IMMUNE-MEDIATED MYOSITIS 396 0.3426
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 267 0.2654
5 MYOPATHY 1816 0.2556
6 HYPERPARATHYROIDISM SECONDARY 578 0.2482
7 NEPHROGENIC ANAEMIA 1025 0.2335
8 RHABDOMYOLYSIS 7473 0.2187
9 ATRIAL TACHYCARDIA 357 0.2076
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]